Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 498

1.

Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice.

Ali A, Bain S, Hicks D, Newland Jones P, Patel DC, Evans M, Fernando K, James J, Milne N, Viljoen A, Wilding J; As part of The Improving Diabetes Steering Committee.

Diabetes Ther. 2019 Jul 18. doi: 10.1007/s13300-019-0670-y. [Epub ahead of print]

PMID:
31321747
2.

Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK.

Bain SC, Bekker Hansen B, Hunt B, Chubb B, Valentine WJ.

J Med Econ. 2019 Jul 17:1. doi: 10.1080/13696998.2019.1645018. [Epub ahead of print]

PMID:
31311364
3.

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice.

Ali A, Bain S, Hicks D, Newland Jones P, Patel DC, Evans M, Fernando K, James J, Milne N, Viljoen A, Wilding J; As part of The Improving Diabetes Steering Committee.

Diabetes Ther. 2019 Jul 9. doi: 10.1007/s13300-019-0657-8. [Epub ahead of print] Review. Erratum in: Diabetes Ther. 2019 Jul 18;:.

PMID:
31290126
4.

Long-term efficacy and safety of combined insulin and GLP-1 therapy: evidence from the LEADER trial.

Tack CJ, Jacob S, Desouza C, Bain SC, Buse JB, Nauck MA, Petrie JR, Poulter NR, Pratley RE, Stegmann HVBK, Bosch-Traberg H, Startseva E, Zinman B; LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Diabetes Obes Metab. 2019 Jul 7. doi: 10.1111/dom.13826. [Epub ahead of print]

PMID:
31282028
5.

Pharmacological treatment for Type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK.

Bain SC, Bakhai A, Evans M, Green A, Menown I, Strain WD.

Diabet Med. 2019 Jun 29. doi: 10.1111/dme.14058. [Epub ahead of print] Review.

PMID:
31254356
6.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.

PMID:
31189511
7.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.

PMID:
31189509
8.

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC; PIONEER 6 Investigators.

N Engl J Med. 2019 Jun 11. doi: 10.1056/NEJMoa1901118. [Epub ahead of print]

PMID:
31185157
9.

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial.

Leiter LA, Bain SC, Hramiak I, Jódar E, Madsbad S, Gondolf T, Hansen T, Holst I, Lingvay I.

Cardiovasc Diabetol. 2019 Jun 6;18(1):73. doi: 10.1186/s12933-019-0871-8.

10.

Static Preload Inhibits Loading-Induced Bone Formation.

Srinivasan S, Balsiger D, Huber P, Ausk BJ, Bain SD, Gardiner EM, Gross TS.

JBMR Plus. 2018 Oct 11;3(5):e10087. doi: 10.1002/jbm4.10087. eCollection 2019 May.

11.

Clumsy hands in a woman with long-standing diabetes.

Morris FM, Bain SC.

Diabet Med. 2019 May 25. doi: 10.1111/dme.14041. [Epub ahead of print] No abstract available.

PMID:
31127641
12.

An unusual finding during retinal screening.

O'Neil LK, Bain SC.

Diabet Med. 2019 Apr 19. doi: 10.1111/dme.13971. [Epub ahead of print] No abstract available.

PMID:
31004377
13.

Foot deformity in a man with Type 2 diabetes.

Taylor K, Bain SC.

Diabet Med. 2019 Mar 21. doi: 10.1111/dme.13950. [Epub ahead of print] No abstract available.

PMID:
30897242
14.

Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials.

Verma S, Bain SC, Monk Fries T, Mazer CD, Nauck MA, Pratley RE, Rasmussen S, Saevereid HA, Zinman B, Buse JB.

Diabetes Obes Metab. 2019 Jul;21(7):1745-1751. doi: 10.1111/dom.13698. Epub 2019 Apr 2.

15.

Neuromuscular dysfunction, independent of gait dysfunction, modulates trabecular bone homeostasis in mice.

Bain SD, Huber P, Ausk BJ, Kwon RY, Gardiner EM, Srinivasan S, Gross TS.

J Musculoskelet Neuronal Interact. 2019 Mar 1;19(1):79-93.

16.

Basal insulin reductions in anticipation of multiple exercise sessions in people with type 1 diabetes-a clinical perspective.

McCarthy O, Bain SC, Deere R.

Ann Transl Med. 2018 Dec;6(Suppl 2):S111. doi: 10.21037/atm.2018.11.63. No abstract available.

17.
18.

A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes.

Davies M, Bain S, Charpentier G, Flacke F, Goyeau H, Woloschak M, Hasslacher C, Vespasiani G, Edelman S.

J Diabetes Sci Technol. 2019 Jan 15:1932296818821706. doi: 10.1177/1932296818821706. [Epub ahead of print]

PMID:
30646755
19.

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.

Verma S, Poulter NR, Bhatt DL, Bain SC, Buse JB, Leiter LA, Nauck MA, Pratley RE, Zinman B, Ørsted DD, Monk Fries T, Rasmussen S, Marso SP.

Circulation. 2018 Dec 18;138(25):2884-2894. doi: 10.1161/CIRCULATIONAHA.118.034516.

PMID:
30566004
20.

Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.

Gilbert MP, Bain SC, Franek E, Jodar-Gimeno E, Nauck MA, Pratley R, Réa RR, Kerr Saraiva JF, Rasmussen S, Tornøe K, von Scholten BJ, Buse JB; and the LEADER Publication Committee on behalf of the LEADER Trial Investigators.

Ann Intern Med. 2018 Dec 4. doi: 10.7326/M18-1569. [Epub ahead of print] No abstract available.

PMID:
30508430

Supplemental Content

Loading ...
Support Center